Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$9.8M
2M shares
52-week range
$3.80 – $12.45
16% from low
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Exchange
NASDAQ
CS
Borrow rate
4.41%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $173.6M | $157.7M | $151.4M | $159.8M | $137.2M | $132.0M | $117.9M | $108.0M |
| Cost of revenue | $34.5M | $31.6M | $35.5M | $34.1M | $33.1M | $29.1M | $26.4M | $27.1M |
| Gross profit | $139.1M | $126.2M | $115.9M | $125.6M | $104.1M | $102.9M | $91.5M | $81.0M |
| Gross margin | 80.1% | 80.0% | 76.5% | 78.6% | 75.9% | 78.0% | 77.6% | 74.9% |
| R&D | $1.0M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$90.0K | $6.4M | $4.5M | $9.0M | −$405.0K | −$964.0K | $1.4M | −$426.0K |
| EBITDA | $2.0M | $8.5M | $9.7M | $10.6M | $3.0M | $498.0K | $5.6M | −$426.0K |
| Net income | −$3.9M | $3.3M | $6.3M | $9.8M | −$4.5M | −$2.2M | $2.5M | −$15.2M |
| Net margin | -2.2% | 2.1% | 4.1% | 6.2% | -3.3% | -1.7% | 2.1% | -14.1% |
| EPS (diluted) | -1.53 | 1.35 | 2.77 | 4.71 | -2.35 | -1.20 | 1.32 | -8.00 |
Annual figures · source: Financial Modeling Prep
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
www.mannatech.comNo one on the platform currently holds MTEX.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 30,878 | $178.5K |
| Execution date | Ratio |
|---|---|
| 2012-01-17 | 1-for-10reverse |
No one on the platform has traded MTEX yet.
| $2M |
| — |
| EDTKSkillful Craftsman Education Technology Limited | $1.01 | +2.75% | $16M | — |
| MWYNMarwynn Holdings, Inc. Common stock | $1.08 | +0.00% | $18M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.1× sales vs its 0.2× historical median P/S.
Fair value ≈ $11.17 · price $5.17 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$MTEX this one is due for a move soon. Keep an eye.,.
View on StockTwits ↗$MTEX selected Yasir Haider as its new chief financial officer, effective June 3.
View on StockTwits ↗$MTEX presented its 2026 annual shareholders meeting results, electing two new directors, ratifying BDO USA as auditor and approving
View on StockTwits ↗@Pacman007 $MTEX very quiet. Nice insider buys recently from multiple members of board & management. This one has NEVER, at least not recently, had significant volume when it has popped. But, hopefully soon--wish they would be more forthright in their PR strategy or somehow generate buzz for the stock.
View on StockTwits ↗$MTEX One of the lowest share structure stocks on Nasdaq with an actually decent business. Yes, they've had growth and profitability issues with the tariffs and some other headwinds but if this ever got real volume or made a pivot towards integrating AI into their business model it could move fast IMO.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.